Hippo Holdings Inc.
HIPO NYSE Fire, Marine & Casualty Insurance Financials FY2020βFY2025
What Hippo Holdings Inc. does
No business description yet.
- Legal name
- Hippo Holdings Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 5, 2026
- Accession Β· CIK
- 0001828105-26-000008
0001828105
Revenue and margins
Hippo Holdings Inc. had $469M of revenue in fiscal 2025, up 25.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $9.1M in fiscal 2025, 1.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Hippo Holdings Inc. returned $14.5M to shareholders in fiscal 2025, 159% of free cash flow. The diluted share count rose 5.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Hippo Holdings Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $785M | $519M | $329M | $198M | $218M |
| Total assets | $1.6B | $1.6B | $1.5B | $1.5B | $1.9B |
| Total liabilities | $781M | $975M | $1.1B | $1.2B | $1.5B |
| Shareholders' equity | $860M | $590M | $378M | $362M | $436M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β7.8% | β18.8% | β10.7% | β11.7% | β5.7% | 2.8% |
| Altman Z'' | β | β | β | β | β | β |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $51.6M | $91.2M | $120M | $210M | $372M | $469M |
| Pretax income | β$143M | β$367M | β$325M | β$263M | β$27.4M | $63.3M |
| Income tax | β$1.8M | $0.7M | $1.3M | $0.5M | $1.2M | $0.7M |
| Net income | β$142M | β$371M | β$333M | β$273M | β$40.5M | $57.7M |
| Net income to common | β$142M | β$371M | β$333M | β$273M | β$40.5M | $57.7M |
| Diluted EPS | β$1.63 | β$34.11 | β$14.66 | β$11.58 | β$1.64 | $2.22 |
| Diluted shares | 0.09B | 0.01B | 0.02B | 0.02B | 0.02B | 0.03B |
| Cash flow | ||||||
| Cash from operations | β$65.4M | β$125M | β$162M | β$92.4M | $47.5M | $9.2M |
| Capital expenditure | $0.4M | $0.8M | $4.9M | $29.6M | $0.3M | $0.1M |
| Free cash flow | β$65.8M | β$125M | β$166M | β$122M | $47.2M | $9.1M |
| Depreciation and amortization | $6.7M | $11.0M | $15.2M | $19.8M | $23.2M | $20.4M |
| Stock-based compensation | $17.2M | $24.3M | $61.9M | $57.5M | $38.2M | $29.3M |
| Acquisitions | $83.7M | $0.6M | β | β | β | β |
| Share buybacks | β | β | $0.0M | $1.8M | $15.6M | $14.5M |
| Dividends and buybacks | β | β | $0.0M | $1.8M | $15.6M | $14.5M |
| Balance sheet | ||||||
| Cash and short-term investments | $452M | $785M | $519M | $329M | $198M | $218M |
| Current assets | $1.7M | β | β | β | β | β |
| Current liabilities | $0.2M | β | β | β | β | β |
| Property and equipment, net | β | $1.1M | $5.4M | $34.9M | $33.0M | $31.6M |
| Goodwill | $47.8M | $53.5M | $0.0M | $0.0M | $0.0M | β |
| Intangible assets | $33.9M | $32.2M | $26.9M | $27.3M | $17.0M | $13.8M |
| Total assets | $979M | $1.6B | $1.6B | $1.5B | $1.5B | $1.9B |
| Total liabilities | $834M | $781M | $975M | $1.1B | $1.2B | $1.5B |
| Shareholders' equity | β$200M | $860M | $590M | $378M | $362M | $436M |
| Margins | ||||||
| Net margin | β274.2% | β407.2% | β278.5% | β130.2% | β10.9% | 12.3% |
| FCF margin | β127.5% | β137.4% | β139.0% | β58.2% | 12.7% | 1.9% |
| Returns | ||||||
| Return on equity | β | β112.5% | β46.0% | β56.4% | β10.9% | 14.5% |
| Return on assets | β14.4% | β28.3% | β20.8% | β17.7% | β2.6% | 3.3% |
| Return on tangible equity | β | β48.0% | β59.2% | β77.9% | β11.7% | 13.7% |
| Growth | ||||||
| Revenue growth | β | 76.7% | 31.3% | 75.2% | 77.4% | 25.9% |
| FCF growth | β | β | β | β | β | β80.7% |
| Share count change | β | β87.5% | 108.9% | 3.7% | 4.8% | 5.3% |
| Financial health | ||||||
| Current ratio | 11.2x | β | β | β | β | β |
| Quick ratio | 11.2x | β | β | β | β | β |
| Capital allocation | ||||||
| Capex / revenue | 0.8% | 0.9% | 4.1% | 14.1% | 0.1% | 0.0% |
| Stock comp / revenue | 33.3% | 26.6% | 51.7% | 27.4% | 10.3% | 6.3% |
| Payouts / FCF | β | β | β | β | 33.1% | 159.3% |
| Quality scores | ||||||
| Accruals ratio | β7.8% | β18.8% | β10.7% | β11.7% | β5.7% | 2.8% |
Source: SEC EDGAR XBRL filings (CIK 0001828105). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.